Elevated serum levels of intercellular adhesion molecule ICAM-1 in Pseudoxanthoma elasticum

Clinica Chimica Acta

Volumn 394, Issue 1-2, 2008, Pages 54-58

  Hendig, Doris ^a   Adam, Alexandra ^a   Zarbock, Ralf ^a   Szliska, Christiane ^b   Kleesiek, Knut ^a   Götting, Christian ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Krankenhaus Bethesda   (Germany)

Author keywords

ABC transporter family C member 6; ABCC6; Adhesion molecules; ICAM 1; MRP6; multidrug resistance associated protein 6; Polymorphism; pseudoxanthoma elasticum; Pseudoxanthoma elasticum; PXE; restriction fragment length polymorphism; RFLP; SD; single nucleotide polymorphism; SNP; standard deviation

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; FEMALE; GENE; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; ICAM 1 GENE; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NONSENSE MUTATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSEUDOXANTHOMA ELASTICUM; QUANTITATIVE ANALYSIS; SEX RATIO;

ALLELES; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PSEUDOXANTHOMA ELASTICUM;

EID: 44649199206     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.04.002     Document Type: Article

References (37)

1. Neldner K., and Struk B. Pseudoxanthoma elasticum. In: Royce P.M., and Steinmann B. (Eds). Connective tissue and its heritable disorders (2002), Wiley-Liss Inc., New York 561-583
2. Scheffer G.L., Hu X., Pijnenborg A.C., Wijnholds J., Bergen A.A., and Scheper R.J. MRP6 (ABCC6) detection in normal human tissues and tumors. Lab Invest 82 (2002) 515-518
3. Jiang Q., and Uitto J. Pseudoxanthoma elasticum: a metabolic disease?. J Invest Dermatol 126 (2006) 1440-1441
4. Passi A., Albertini R., Baccarani Contri M., et al. Proteoglycan alterations in skin fibroblast cultures from patients affected with pseudoxanthoma elasticum. Cell Biochem Funct 14 (1996) 111-120
5. Götting C., Hendig D., Adam A., et al. Elevated xylosyltransferase I activities in pseudoxanthoma elasticum (PXE) patients as a marker of stimulated proteoglycan biosynthesis. J Mol Med 83 (2005) 984-992
6. Hendig D., Schulz V., Arndt M., Szliska C., Kleesiek K., and Götting C. Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin Chem 52 (2006) 227-234
7. Hendig D., Zarbock R., Szliska C., Kleesiek K., and Götting C. The local calcification inhibitor matrix Gla protein in pseudoxanthoma elasticum. Clin Biochem 41 (2008) 407-412
8. Pasquali-Ronchetti I., Garcia-Fernandez M.I., Boraldi F., et al. Oxidative stress in fibroblasts from patients with pseudoxanthoma elasticum: possible role in the pathogenesis of clinical manifestations. J Pathol 208 (2006) 54-61
9. Zarbock R., Hendig D., Szliska C., Kleesiek K., and Götting C. Pseudoxanthoma elasticum: genetic variations in antioxidant genes are risk factors for early disease onset. Clin Chem 53 (2007) 1734-1740
10. Springer T.A. Adhesion receptors of the immune system. Nature 346 (1990) 425-434
11. Witkowska A.M., and Borawska M.H. Soluble intercellular adhesion molecule-1 (sICAM-1): an overview. Eur Cytokine Netw 15 (2004) 91-98
12. Schwartz E., Cruickshank F.A., and Lebwohl M.G. Elastase-like protease and elastolytic activities expressed in cultured dermal fibroblasts derived from lesional skin of patients with pseudoxanthoma elasticum, actinic elastosis, and cutis laxa. Clin Chim Acta 176 (1988) 219-224
13. Quaglino D., Sartor L., Garbisa S., et al. Dermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 degradative potential. Biochim Biophys Acta 1741 (2005) 42-47
14. Götting C., Adam A., Szliska C., and Kleesiek K. Circulating P-, L- and E-selectins in pseudoxanthoma elasticum patients. Clin Biochem 41 (2008) 368-374
15. Brevetti G., De Caterina M., Martone V.D., et al. Exercise increases soluble adhesion molecules ICAM-1 and VCAM-1 in patients with intermittent claudication. Clin Hemorheol Microcirc 24 (2001) 193-199
16. Sharief M.K., Noori M.A., Ciardi M., Cirelli A., and Thompson E.J. Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage. J Neuroimmunol 43 (1993) 15-21
17. Reilly M.P., Wolfe M.L., Dykhouse J., Reddy K., Localio A.R., and Rader D.J. Intercellular adhesion molecule 1 (ICAM-1) gene variant is associated with coronary artery calcification independent of soluble ICAM-1 levels. J Investig Med 52 (2004) 515-522
18. Kamiuchi K., Hasegawa G., Obayashi H., et al. Intercellular adhesion molecule-1 (ICAM-1) polymorphism is associated with diabetic retinopathy in Type 2 diabetes mellitus. Diabet Med 19 (2002) 371-376
19. Puthothu B., Krueger M., Bernhardt M., and Heinzmann A. ICAM1 amino-acid variant K469E is associated with paediatric bronchial asthma and elevated sICAM1 levels. Genes Immun 7 (2006) 322-326
20. Lebwohl M., Neldner K., Pope F.M., et al. Classification of pseudoxanthoma elasticum: report of a consensus conference. J Am Acad Dermatol 30 (1994) 103-107
21. Schulz V., Hendig D., Henjakovic M., Szliska C., Kleesiek K., and Götting C. Mutational analysis of the ABCC6 gene and the proximal ABCC6 gene promoter in German patients with pseudoxanthoma elasticum (PXE). Hum Mutat 27 (2006) 831
22. Ponthieux A., Herbeth B., Droesch S., Lambert D., and Visvikis S. Age- and sex-related reference values for serum adhesion molecule concentrations in healthy individuals: intercellular adhesion molecule-1 and E-, P-, and L-selectin. Clin Chem 49 (2003) 1544-1546
23. Sasieni P.D. From genotypes to genes: doubling the sample size. Biometrics 53 (1997) 1253-1261
24. Skol A.D., Scott L.J., Abecasis G.R., and Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38 (2006) 209-213
25. Dupont W.D., and Plummer Jr. W.D. Power and sample size calculations. A review and computer program. Control Clin Trials 11 (1990) 116-128
26. Waters C.E., Shi-Wen X., Denton C.P., Abraham D.J., and Pearson J.D. Signaling pathways regulating intercellular adhesion molecule 1 expression by endothelin 1: comparison with interleukin-1beta in normal and scleroderma dermal fibroblasts. Arthritis Rheum 54 (2006) 649-660
27. Taylor K.R., and Gallo R.L. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J 20 (2006) 9-22
28. Ilias A., Urban Z., Seidl T.L., et al. Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J Biol Chem 277 (2002) 16860-16867
29. Clayton A., Evans R.A., Pettit E., Hallett M., Williams J.D., and Steadman R. Cellular activation through the ligation of intercellular adhesion molecule-1. J Cell Sci 111 Pt 4 (1998) 443-453
30. Maccari F., Gheduzzi D., and Volpi N. Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum. Clin Chem 49 (2003) 380-388
31. Longas M.O., Wisch P., Lebwohl M.G., and Fleischmajer R. Glycosaminoglycans of skin and urine in pseudoxanthoma elasticum: evidence for chondroitin 6-sulfate alteration. Clin Chim Acta 155 (1986) 227-236
32. Oertli B., Beck-Schimmer B., Fan X., and Wuthrich R.P. Mechanisms of hyaluronan-induced up-regulation of ICAM-1 and VCAM-1 expression by murine kidney tubular epithelial cells: hyaluronan triggers cell adhesion molecule expression through a mechanism involving activation of nuclear factor-kappa B and activating protein-1. J Immunol 161 (1998) 3431-3437
33. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90 (2002) 251-262
34. Hu X., Plomp A.S., van Soest S., Wijnholds J., de Jong P.T., and Bergen A.A. Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update. Surv Ophthalmol 48 (2003) 424-438
35. Chassaing N., Martin L., Mazereeuw J., et al. Novel ABCC6 mutations in pseudoxanthoma elasticum. J Invest Dermatol 122 (2004) 608-613
36. Klimiuk P.A., Sierakowski S., Latosiewicz R., et al. Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. Ann Rheum Dis 61 (2002) 804-809
37. Gaetani E., Flex A., Pola R., et al. The K469E polymorphism of the ICAM-1 gene is a risk factor for peripheral arterial occlusive disease. Blood Coagul Fibrinolysis 13 (2002) 483-488